Abercrombie & Fitch lifts annual sales forecast-March 2024-www.financetom.com

Abercrombie & Fitch lifts annual sales forecast

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

Abercrombie & Fitch lifts annual sales forecast

Nov 26, 2024 4:55 AM

Nov 26 (Reuters) - Abercrombie & Fitch ( ANF ) lifted

its annual sales forecast on Tuesday, betting on strong demand

at its namesake label and its teen-focused Hollister brand.

The company now expects fiscal 2024 net sales to rise 14% to

15%, compared with its prior forecast of 12% to 13% growth.

Previous page： SpringWorks Therapeutics Submits New-Drug Application to FDA for Mirdametinib Next page： Olin, Westlake Lodge Anti-Dumping Complaint to European Commission Against Four Countries

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

SpringWorks Therapeutics Submits New-Drug Application to FDA for Mirdametinib

Jul 1, 2024

07:44 AM EDT, 07/01/2024 (MT Newswires) -- SpringWorks Therapeutics ( SWTX ) said Monday that it has submitted a new-drug application to the US Food and Drug Administration for mirdametinib to treat patients with neurofibromatosis type 1- associated plexiform neurofibromas, a rare genetic disorder. The submission includes data from a phase 2b trial that evaluated mirdametinib in patients two years...

Olin, Westlake Lodge Anti-Dumping Complaint to European Commission Against Four Countries

Jul 1, 2024

07:44 AM EDT, 07/01/2024 (MT Newswires) -- Olin (OLN) said Monday that the European Commission has lodged an anti-dumping complaint concerning imports of epoxy resins from China, South Korea, Taiwan, and Thailand. The European Commission took action after a complaint from Olin, Westlake (WLK), and Spolchemie, known as members of the Ad Hoc Coalition of Epoxy Resin Producers, to probe...

AstraZeneca's Imfinzi, Lynparza Combination Recommended for Approval in Europe as Endometrial Cancer Treatment

Jul 1, 2024

07:41 AM EDT, 07/01/2024 (MT Newswires) -- AstraZeneca ( AZN ) said in a Monday filing that the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, has recommended approval for the combination of Lynparza and Imfinzi as a treatment for certain patients with primary advanced or recurrent endometrial cancer. The company said Lynparza and Imfinzi have...

KKR, Teachers' Venture Growth Co-lead $140 Million Series E Financing Round of Japanese HR Management Platform SmartHR

Jul 1, 2024

07:38 AM EDT, 07/01/2024 (MT Newswires) -- KKR (KKR) said Monday it has agreed with the investment arm of Ontario Teachers' Pension Plan to jointly lead a $140 million Series E financing round of SmartHR, a human resources management platform in Japan. In addition to KKR and Teachers' Venture Growth, SmartHR's existing shareholders also participated in the round. SmartHR will...